- Category
- Micro (2022-23)
- Udyam number
- UDYAM-TN-03-0097354

Crantor Pharmaceuticals Private Limited
About Crantor Pharmaceuticals Private Limited
Data last updated:
Crantor Pharmaceuticals Private Limited is a private limited company based in Coimbatore, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 March 2022.
The company is registered with the Registrar of Companies (ROC), Coimbatore, under CIN U24299TZ2022PTC038478.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹50,000. It was formerly known as Asura Pharma Private Limited. It is led by directors Lakshmanan Subash and Nithiyanandham Karthikeyan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.503/8 Ellai Thottam Road Peelamedu, Coimbatore, Tamil Nadu, India – 641004.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.22 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹7.33 Lakh (net margin 6%) and EBITDA of ₹8.37 Lakh (EBITDA margin 6.9%).
Crantor Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-03-0097354).
Company details
Recognitions & Rankings of Crantor Pharmaceuticals
Contact details
Crantor Pharmaceuticals Private Limited's registered office is in Coimbatore, Tamil Nadu.
- Registered AddressNo.503/8 Ellai Thottam Road Peelamedu, Coimbatore, Tamil Nadu, India – 641004
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Crantor Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Crantor Pharmaceuticals Private Limited, buy the company report.
Financials of Crantor Pharmaceuticals Private Limited
FY 2025 filings availableCrantor Pharmaceuticals Private Limited reported revenue of ₹1.22 Cr (up 266% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 266% in the latest year. EBITDA rose 289% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹8.37 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹7.33 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 6.9% | |||
| Net Profit Margin | 6% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Crantor Pharmaceuticals Private Limited, buy the company report.
Board of directors of Crantor Pharmaceuticals Private Limited
Crantor Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Lakshmanan Subash | Director | 21 Mar 2022 | 4 Years 7 Months | Current |
| Nithiyanandham Karthikeyan | Director | 21 Mar 2022 | 4 Years 7 Months | Current |
Legal cases
No court or tribunal cases involving Crantor Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Crantor Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Crantor Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Crantor Pharmaceuticals Private Limited has 3 board changes on record since 2022: 2 appointments and 1 cessation. The latest: Perumalsamy Rameshkumar ceased to be Director on 29 Oct 2022.
Frequently asked questions
Crantor Pharmaceuticals is an active private limited company based in Coimbatore, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 March 2022 (4+ years old) and is registered under CIN U24299TZ2022PTC038478.
Crantor Pharmaceuticals has 2 current directors:
- Lakshmanan Subash - Director
- Nithiyanandham Karthikeyan - Director
The latest financial statements of Crantor Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Crantor Pharmaceuticals is U24299TZ2022PTC038478. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Crantor Pharmaceuticals was incorporated on 21 March 2022, making it 4+ years old. It is registered with the Registrar of Companies, Coimbatore.
Perumalsamy Rameshkumar ceased to be Director on 29 Oct 2022. Lakshmanan Subash was appointed as Director on 21 Mar 2022. Nithiyanandham Karthikeyan was appointed as Director on 21 Mar 2022.
Yes, Crantor Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-03-0097354).
The registered office of Crantor Pharmaceuticals is at No.5038 Ellai Thottam Road Peelamedu, Coimbatore, Tamil Nadu, India – 641004.
Crantor Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Yes. Crantor Pharmaceuticals was formerly known as Asura Pharma Private Limited.

